Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 21, 2017
Pharmacy Choice - News - Drug Delivery Systems - November 21, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 106     Next >>     Go To Page:

11/21/17 - Aequus Granted European Patent for Once-Weekly Transdermal Aripiprazole
VANCOUVER- Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that the European Patent Office has issued an intention to grant a European patent for AQS1301, Aequus' once-weekly transdermal patch containing aripiprazole. This is the eighth...
11/21/17 - Auto-Injectors Market Expected to Witness a Sustainable Growth over 2016 - 2026: The market is anticipated to exhibit a CAGR of 15.1% during the forecast period and is projected to be valued at nearly US$ 7,000 Mn by the end of 2026.
Valley Cottage, NY 11/20/2017 Improving healthcare infrastructure across several countries and regions, coupled with availability of well-developed manufacturing units, facilitates the growth of medical device businesses. In the report, titled "Auto-Injectors Market: Global Industry Analysis and Opportunity Assessment, 2016-2026," nearly...
11/21/17 - BioQ Pharma and Sophos Biotech Enter into Strategic Partnership for Post-Operative Analgesia Therapy in Italy [Syrian Arab News Agency]
-BioQ Pharma Incorporated and Sophos Biotech S.r.l., both specialty pharmaceutical companies, today announced a strategic partnership agreement under which BioQ will supply and Sophos will commercialize a proprietary treatment for post-operative pain management in Italy. Giulio Cimini, CEO of Sophos, stated, We are very pleased to join with BioQ to
11/21/17 - Cipla Receives Final Approval for Generic Pulmicort Respules
India, Mumbai- Cipla Ltd, a global pharmaceutical company, today announced that it has received final approval for its Abbreviated New Drug Application for Budesonide Inhalation Suspension, 0.25 mg/2mL, 0.5 mg/2mL, and 1 mg/2mL from the United States Food and Drug Administration to market a generic version of Astrazeneca's Pulmicort Respules.
11/21/17 - Determination That TRINTELLIX (Vortioxetine Hydrobromide) Oral Tablet, EQ 15 Milligram Base, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
This determination will allow FDA to approve abbreviated new drug applications for vortioxetine hydrobromide oral tablet, 15 mg base, if all other legal and regulatory requirements are met. The 1984 amendments include what is now section 505 of the Federal Food, Drug, and Cosmetic Act, which requires FDA to publish a list of all approved drugs.
11/21/17 - Drug Delivery Infusion Systems Market - Medical Devices Pipeline Assessment, 2017 - Acute Market Reports
Global Drug Delivery Infusion Systems Market- Medical Devices Pipeline Assessment, 2017. Drug Delivery Infusion Systems Market- Medical Devices Pipeline Assessment, 2017. *Extensive coverage of the Drug Delivery Infusion Systems under development* The report reviews details of major pipeline products which includes, product description, licensing a
11/21/17 - Drug Delivery Infusion Systems Market Medical Devices Pipeline Assessment, 2017 Acute Market Reports
"Acute Market Reports Logo" Global Drug Delivery Infusion Systems Market- Medical Devices Pipeline Assessment, 2017 Drug Delivery Infusion Systems Market- Medical Devices Pipeline Assessment, 2017. Medical Devices sector report, Drug Delivery Infusion Systems- Medical Devices Pipeline Assessment, 2017 "provides an overview of Drug Delivery Infusion
11/21/17 - Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian Technology [T-break Tech (Middle East)]
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced the company was awarded a grant from InnoBooster to develop a novel oral delivery system using a new application of Egalet`s Guardian Technology to...
11/21/17 - Global Insulin Pump Market Poised To Garner USD 8520.9 Million By 2023
Global Insulin Pump Market Information, by types; by end users- Forecast to 2023. Insulin Pumps are a medical device that is used for dispensing insulin as required in the treatment of diabetes and is also alternatively known as continuous subcutaneous insulin infusion therapy. According to a Market Research Future report on Insulin Pump Market Res
11/21/17 - Home Infusion Therapy Market Is Poised to Reach US$ 26,747.8 Mn in Terms of Revenue by 2020: In cases of gastrointestinal diseases, diabetes and cancer-related pain infusion therapy is common. Moreover, infusion therapy is equally effective in treati
Albany, NY 11/20/2017 According to a new market report published by Persistence Market Research "Global Market Study on Home Infusion Therapy Devices- Needleless Connectors to Witness Highest Growth by 2020", the global home infusion therapy devices market was valued at US$ 15,905.1 Mn in 2014 and is expected to grow at a CAGR of 9% from 2014
11/21/17 - Injectable Drug Delivery Devices Market Survey Report 2017
ReportsMonitor.com has added the report, "Global Injectable Drug Delivery Devices Market Professional Survey Report 2017." The far reaching research study offers a 360-degree analysis of the market crosswise over different unequiv...
11/21/17 - Kalo auto-injector for infants approved Kaleo auto-injector for infants approved
Richmond-based pharmaceutical company Kalo has received federal approval to market an epinephrine auto-injector to treat life-threatening allergic reactions in babies as small as 16.5 pounds. The U.S. Food and Drug Administration on Friday tweeted approval for a new dosage of Kalo's Auvi-Q epinephrine device. Vivian Hernandez-Trujillo, a Miami-
11/21/17 - Medherant awarded Excellence in Science & Technology Award [Syrian Arab News Agency]
Medherant, founded by Professor David Haddleton and the University of Warwick in 2015, has created a drug delivery platform, TEPI Patch, designed to address many of the disadvantages of previous transdermal drug delivery patches. It enables a wider range of drugs to be delivered through the skin, has increased drug loading capacity, and provides a
11/21/17 - Phase 3 MURANO Study of Venetoclax Chosen as Late-Breaking Abstract at the 2017 American Society of Hematology Annual Meeting & Exposition, Highlighting AbbVie's Commitment to Helping Blood Cancer Patients
AbbVie, a global research and development-based biopharmaceutical company, today announced that the American Society of Hematology has accepted data from the Phase 3 MURANO study evaluating venetoclax tablets in combination with rituximab in patients with relapsed/refractory chronic lymphocytic leukemia, as an oral, late-breaking presentation...
11/21/17 - Report Summarizes Drug Delivery Systems Study Findings from Department of Biomedical Engineering (Vessel-Targeted Chemophototherapy with Cationic...
Report Summarizes Drug Delivery Systems Study Findings from Department of Biomedical Engineering. By a News Reporter-Staff News Editor at Cancer Weekly Researchers detail new data in Drugs and Therapies- Drug Delivery Systems. Our news journalists obtained a quote from the research from the Department of Biomedical Engineering, "Near-infrared lig
11/21/17 - Theravance Biopharma to Present at Two Upcoming Investor Conferences
Theravance Biopharma, Inc. announced today that members of management will participate in fireside chats at two upcoming investor conferences:. A live broadcast of each event will be available by visiting the Investor Relations section of Theravance Biopharma's website at www.theravance.com, under the Presentations& Events tab. Theravance Biophar
11/21/17 - ViaDerma, Inc. is Granted Approval to sell VitaStem(TM) its FDA Registered Topical Antibiotic on Amazon.com and Expands Testing into Major US Hospital Chains to Ramp Up Domestic Sales & Begins Production of New Products
ViaDerma, Inc., a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has begun sales and distribution of its highly anticipated topical antibiotic ointment. Its marketing, sales and distribution partner, Biogenx, Inc. has been preselling the product, under the name of VitaStem?.
11/20/17 - AcelRx Pharmaceuticals Reports Publication of Manuscript Evaluating Sufentanil Sublingual Tablets for Moderate-to-Severe Acute Pain in the Emergency...
By a News Reporter-Staff News Editor at Clinical Trials Week AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, reported the publication of a manuscript analyzing sufentanil sublingual tablet 30 mcg for...
11/20/17 - Biohaven Receives Agreement From FDA on Initial Pediatric Study Plan for Rimegepant, a Second Generation Oral CGRP-Receptor Antagonist for the Acute Treatment of Migraine
Biohaven Pharmaceutical Holding Company Ltd. announced today that the Company has received agreement from the U.S. Food and Drug Administration on the initial pediatric study plan for orally-dosed rimegepant. "We are pleased to have the FDA's agreement on an iPSP, which marks another key milestone in our CGRP development program," said Vlad Cori
11/20/17 - BioQ Pharma and Sophos Biotech Enter into Strategic Partnership for Post-Operative Analgesia Therapy in Italy
BioQ Pharma Incorporated and Sophos Biotech S.r.l., both specialty pharmaceutical companies, today announced a strategic partnership agreement under which BioQ will supply and Sophos will commercialize a proprietary treatment for post-operative pain management in Italy.. BioQ Pharma Incorporated is a privately held specialty pharmaceutical compan
11/20/17 - CERENIS Therapeutics Acquires LYPRO Biosciences Expanding Its HDL Strategy Into Immuno-Oncology and Chemotherapeutic Drug Delivery
By a News Reporter-Staff News Editor at Clinical Trials Week Regulatory News: CERENIS Therapeutics an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular and metabolic diseases, announces the acquisition of LYPRO Biosciences assets, a portfolio of...
11/20/17 - Connected Injectable Drug Delivery Devices Market - Forecast (2017-2023) - Research and Markets
The "Connected Injectable Drug Delivery Devices Market: By Device Type; By Technology; By Application; By End User& By Geography- Forecast" report has been added to Research and Markets' offering. Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significan
11/20/17 - Connected Injectable Drug Delivery Devices Market: Forecast (2017-2023)
Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition. These drug delivery devices helps in addressing the patient consistence issues with the medication treatment, disease management protocols which are..
11/20/17 - Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian? Technology
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced the company was awarded a grant from InnoBooster to develop a novel oral delivery system using a new application of Egalet's Guardian Technology to...
11/20/17 - Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes
Geron Corporation today announced that the first patient has been dosed in the expanded Part 1 of IMerge, the ongoing Phase 2/ 3 clinical trial of imetelstat in transfusion dependent patients with Low or Intermediate-1 risk myelodysplastic syndromes who are refractory or resistant to treatment with an erythropoiesis stimulating agent.
Articles(s): 1 - 25 of 106     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415